Multimodal approach for identification and validation of hepatocellular carcinoma targets for radiotheranostics
Philip Homan, Joon-Yong Chung, Woonghee Lee, Divya Nambiar, Julia Sheehan-Klenk, Hima Makala, Stanley Fayn, Orit Jacobson, Arthur Paden King, Kyungeun Kim, Jeong Won Kim, Sung Ryol Lee, Maggie Cam, Stephen M. Hewitt, Xin Wei Wang, Mitchell Ho, Freddy E. Escorcia
Theranostics 2026; doi:10.7150/thno.136906; in press
Author manuscript

The Evolution of Surrogate Microspheres in Transarterial Radioembolization: From SPECT Prediction to Multimodal, AI-Guided Precision Dosimetry
Arun Gupta, Andrew C. Gordon, Samdeep K. Mouli, Robert J. Lewandowski, and Dong-Hyun Kim
Theranostics 2026; doi:10.7150/thno.134985; in press
Author manuscript

Novel nastorazepide-based radioligands demonstrate excellent Cholecystokinin-2 Receptor targeting and theranostic potential
Lennart Bohrmann, Doroteja Novak, Marko Kroselj, Raghuvir H. Gaonkar, Francesca Porto, Melpomeni Fani, Petra Kolenc, Marko Anderluh, Rosalba Mansi
Theranostics 2026; doi:10.7150/thno.129327; in press
Author manuscript

Multifunctional nanozyme platforms in central nervous system therapies: from rational design to translational medicine
Shufang Niu, Xiaoyin Liu, Ran Xu, An Zhu, Shihong Zhu, Fuheng Hu, Kunlun Ding, Siyi Li, Bingcan Zhu, Peize Liang, Siqi Zhang, Anqi Xiao, Kelong Fan, Zhiyong Zhang
Theranostics 2026; doi:10.7150/thno.136080; in press
Author manuscript